Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma

Cancer

Volumn 115, Issue 20, 2009, Pages 4775-4782

  Chamberlain, Marc C ^a   Johnston, Sandra K ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Intracranial; Platinum chemotherapy refractory; Recurrent; Supratentorial ependymoma; Temozolomide

Indexed keywords

CARBOPLATIN; CISPLATIN; DEXAMETHASONE; GRANISETRON; ONDANSETRON; TEMOZOLOMIDE;

ADULT; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG FATALITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EPENDYMOMA; EVENING DOSAGE; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; INTRACRANIAL SUPRATENTORIAL EPENDYMOMA; LEUKEMIA; LEUKOPENIA; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; CARBOPLATIN; CISPLATIN; DACARBAZINE; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; EPENDYMOMA; FEMALE; FERROUS COMPOUNDS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETREATMENT; SUPRATENTORIAL NEOPLASMS;

EID: 70350112425     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24524     Document Type: Article

References (36)

1. Marks JE, Adler SJ. A comparative study of ependymomas by site of origin. Int J Radiat Oncol Biol Phys. 1990;8:37-43.
2. Dohrmann GJ, Farwell JR, Flannery JT. Ependymomas and ependymoblastomas in children. J Neurosurg. 1976;45: 273-283.
3. Kovalic JJ, Flaris N, Grigsby PW, et al. Intracranial ependymoma long-term outcome, patterns of failure. J Neurooncol. 1993;15:125-131. (Pubitemid 23136027)
4. Chiu JK, Woo SY, Ater J, et al. Intracranial ependymoma in children: analysis of prognostic factors. J Neurooncol. 1992;13:283-290.
5. Robertson PL, Zeltzer PM, Boyeyy JM, et al. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report on the Children's Cancer Group. J Neurosurg. 1998;88:695-703. (Pubitemid 28145213)
6. Duffner PK, Krischer JP, Sanford RA, et al. Prognostic factors in infants and very young children with intracranial ependymomas. Pediatr Neurosurg. 1998;28:215-222. (Pubitemid 28402001)
7. Goldwein JW, Leahy JM, Packer RJ, et al. Intracranial ependymomas in children. Int J Radiat Oncol Phys. 1990; 19:1497-1502.
8. Packer RJ. Ependymomas in children. J Neurosurg. 2000; 93:721-722.
9. Van Veelen-Vincent MRC, Pierre-Kahn A, Kalifa C, et al. Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy. J Neurosurg. 2002;97:827-835. (Pubitemid 35222404)
10. Comi AM, Backstrom JW, Burger PC, Duffner PK. Clinical and neuroradiological findings in infants with intracranial ependymomas. Pediatric Oncology Group. Pediatr Neurol. 1998;18:23-29.
11. Reni M, Brandes AA. Current management and prognostic factors for adult ependymoma. Expert Rev Anticancer Ther. 2002;2:537-545. (Pubitemid 35174383)
12. Guyotat J, Signorelli F, Desme S, et al. Intracranial ependymomas in adult patients: analyses of prognostic factors. J Neurooncol. 2002;60:255-268. (Pubitemid 35439180)
13. Paulino AC, Wen BC, Buatti JM, et al. Intracranial ependymomas: an analysis of prognostic factors and patterns of failure. Am J Clin Oncol. 2002;25:117-122. (Pubitemid 34293061)
14. Reni M, Brandes AA, Vavassori V, et al. A Multicenter study of the prognosis and treatment of adult brain ependymal tumors. Cancer. 2004;100:1221-1229. (Pubitemid 38325951)
15. Schwartz TH, Kim S, Glick RS, et al. Supratentorial ependymomas in adult patients. Neurosurgery. 1999;44:721-731.
16. Merchant TE. Current management of childhood ependymoma. Oncology. 2002;16:629-648.
17. Rogers L, Pueschel J, Spetzler R, et al. Is gross total resection sufficient treatment for posterior fossa ependymomas? J Neurosurg. 2005;102:629-636.
18. Figarella-Branger D, Civatte M, Bouvier-Labit C, et al. Prognostic factors in intracranial ependymomas in children. J Neurosurg. 2000;93:605-613. (Pubitemid 32799294)
19. Healey EA, Barnes PD, Kupsky WJ, et al. The prognostic significance of postoperative residual tumor ependymoma. Neurosurgery. 1991;28:666-671.
20. Stuben G, Stuschke M, Kroll M, Havers W, Sack H. Postoperative radiotherapy of spinal and intracranial ependymomas: analyses of prognostic factors. Radiother Oncol. 1997;45:3-10. (Pubitemid 27448973)
21. Goldwein JW, Glauser TA, Packer RJ, et al. Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors. Cancer. 1990;66:557-563.
22. Garrett PG, Simpson WJ. Ependymomas: results of radiation treatment. Int J Radiat Oncol Biol Phys. 1983;9:1121-1124.
23. Grill J, Kalifa C, Doz F, et al. A high dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase 2 study. Pediatr Neurosurg. 1996;25:7-12.
24. Mason WP, Goldman S, Yates AJ, Boyett J, Li H, Finaly JL. Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma-A report of Children's Cancer Group. J Neurooncol. 1998;37:135-143. (Pubitemid 28073586)
25. Grill J, Le Deley MC, Gambarelli D, et al. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol. 2001;19:1288-1296. (Pubitemid 32202532)
26. Bouffet E, Forman N. Chemotherapy for intracranial ependymoma. Childs Nerv Syst. 1999;15:563-570.
27. Needle MN, Goldwein JW, Grass J, et al. Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Cancer. 1997;80:341-347. (Pubitemid 27282329)
28. Begemann M, DeAngelis LM. Chemotherapeutic treatment of ependymomas at Memorial Sloan-Kettering Cancer Center (MSKCC) from 1994 to 2000. Memorial Sloan-Kettering Cancer Center, New York, NY [abstract]. Proc Am Soc Clin Oncol. 2001;20:65a. Abstract 258.
29. Chamberlain MC. Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide. Pediatr Neurol. 2001;24:117-121.
30. Brandes A, Cavallo G, Reni M, et al. A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia. Cancer. 2005;104:143-148. (Pubitemid 40847762)
31. Gornet MK, Buckner JC, Marks RS, Scheithauer BW, Erickson BJ. Chemotherapy for advanced CNS ependymoma. J Neurooncol. 1999;45:61-67.
32. Nicholson HS, Kretschmar CS, Krailo M, et al. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report for the Children's Oncology Group. Cancer. 2007;110:1542-1550. (Pubitemid 47463069)
33. Aggarwal R, Yeung D, Kumar P, Muhlbauer M, Kun LE. Efficacy and feasibility of stereotactic radiosurgery in the primary management of unfavorable pediatric ependymoma. Radiother Oncol. 1997;43:269-273. (Pubitemid 27248471)
34. Stafford SL, Pollock BE, Foote RL, et al. Stereotactic radiosurgery for recurrent ependymoma. Cancer. 2000;88:870-875.
35. Macdonald DR, Cascino TL, Schold SC, Cairncross JG. Response criteria for phase II studies of supratentorial malignant gliomas. J Clin Oncol. 1990;8:1277-1280.
36. Gilbertson RJ, Bentley L, Hernan R, et al. ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease. Clin Cancer Res. 2002;8:3054-3064. (Pubitemid 35155014)